Respiratory
News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
Almac, AstraZeneca Strike CDx Development Pact
Almac will develop companion diagnostic for use with AstraZeneca pharmaceuticals in a range of therapeutic areas.
As the firm continues to develop assays to run on a current batch-based MDx system, it seeks to develop a more flexible, random-access testing platform.
BugSeq Bioinformatics Nabs BARDA Grant to Develop NGS-Based Respiratory Test
BugSeq will optimize a test for commercial clinical use by lowering the turnaround time, reducing interference from host RNA, and analytically validating the platform.
Meridian Bioscience Gets Additional $2.5M NIH Award to Develop Revogene Respiratory Panel
The award comes after the company received $5.5 million from the agency last year to support the research, development, and increased production of the test.
After shipping 16 million respiratory test cartridges in the third quarter, the firm forecasts another 16 million tests to be sold in the final quarter of 2021.